TYZINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tyzine, and when can generic versions of Tyzine launch?
Tyzine is a drug marketed by Fougera Pharms and is included in one NDA.
The generic ingredient in TYZINE is tetrahydrozoline hydrochloride. There are two drug master file entries for this compound. Additional details are available on the tetrahydrozoline hydrochloride profile page.
Summary for TYZINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 105 |
Patent Applications: | 1,318 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TYZINE at DailyMed |
US Patents and Regulatory Information for TYZINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fougera Pharms | TYZINE | tetrahydrozoline hydrochloride | SOLUTION;NASAL | 086576-002 | Approved Prior to Jan 1, 1982 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Fougera Pharms | TYZINE | tetrahydrozoline hydrochloride | SOLUTION;NASAL | 086576-001 | Approved Prior to Jan 1, 1982 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Fougera Pharms | TYZINE | tetrahydrozoline hydrochloride | SPRAY;NASAL | 086576-003 | Approved Prior to Jan 1, 1982 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |